Skip to content
10-Q

Quarterly Report

SAGENT PHARMACEUTICALS, INC.

0001564590-16-022994

← back to feed
Filed
Aug 5, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Jul 29, 2016 32.91M sh
Shares Diluted Q2 2016 · Jun 30, 2016 32.86M sh
Shares Diluted Q2 2016 · Jun 30, 2016 32.84M sh
Shares Diluted Q2 2016 · Jun 30, 2015 32.16M sh
Shares Diluted Q2 2016 · Jun 30, 2015 32.1M sh
Capex Q2 2016 · Jun 30, 2016 $6.05M
Capex Q2 2016 · Jun 30, 2015 $3.19M
Long Term Debt Q2 2016 · Jun 30, 2016 $5.98M
Long Term Debt Q2 2016 · Dec 31, 2015 $1.62M
Short Term Investments Q2 2016 · Jun 30, 2016 $20.16M
Short Term Investments Q2 2016 · Dec 31, 2015 $20.06M
Cash And Equivalents Q2 2016 · Jun 30, 2016 $15.52M
Cash And Equivalents Q2 2016 · Dec 31, 2015 $28.96M
Cash And Equivalents Q2 2016 · Jun 30, 2015 $50.95M
Cash And Equivalents Q2 2016 · Dec 31, 2014 $55.63M
Stockholders Equity Q2 2016 · Jun 30, 2016 $253.84M
Stockholders Equity Q2 2016 · Dec 31, 2015 $251.09M
Current Liabilities Q2 2016 · Jun 30, 2016 $85.82M
Current Liabilities Q2 2016 · Dec 31, 2015 $83.66M
Total Liabilities Q2 2016 · Jun 30, 2016 $105.18M
Total Liabilities Q2 2016 · Dec 31, 2015 $98.64M
Current Assets Q2 2016 · Jun 30, 2016 $185.02M
Current Assets Q2 2016 · Dec 31, 2015 $191.59M
Total Assets Q2 2016 · Jun 30, 2016 $359.01M
Total Assets Q2 2016 · Dec 31, 2015 $349.73M
Eps Diluted Q2 2016 · Jun 30, 2016 −$0.02
Eps Diluted Q2 2016 · Jun 30, 2016 −$0.17
Eps Diluted Q2 2016 · Jun 30, 2015 −$0.01
Eps Diluted Q2 2016 · Jun 30, 2015 −$0.07
Eps Basic Q2 2016 · Jun 30, 2016 −$0.02
Eps Basic Q2 2016 · Jun 30, 2016 −$0.17
Eps Basic Q2 2016 · Jun 30, 2015 −$0.01
Eps Basic Q2 2016 · Jun 30, 2015 −$0.07
Sga Expense Q2 2016 · Jun 30, 2016 $11.73M
Sga Expense Q2 2016 · Jun 30, 2016 $23.85M
Sga Expense Q2 2016 · Jun 30, 2015 $11.41M
Sga Expense Q2 2016 · Jun 30, 2015 $24.54M
Rd Expense Q2 2016 · Jun 30, 2016 $6.63M
Rd Expense Q2 2016 · Jun 30, 2016 $13.39M
Rd Expense Q2 2016 · Jun 30, 2015 $5.42M
Rd Expense Q2 2016 · Jun 30, 2015 $10.73M
Net Income Q2 2016 · Jun 30, 2016 −$515K
Net Income Q2 2016 · Jun 30, 2016 −$5.51M
Net Income Q2 2016 · Jun 30, 2015 −$256K
Net Income Q2 2016 · Jun 30, 2015 −$2.15M
Operating Income Q2 2016 · Jun 30, 2016 −$469K
Operating Income Q2 2016 · Jun 30, 2016 −$7.69M
Operating Income Q2 2016 · Jun 30, 2015 $1.19M
Operating Income Q2 2016 · Jun 30, 2015 $1M
Gross Profit Q2 2016 · Jun 30, 2016 $17.35M
Gross Profit Q2 2016 · Jun 30, 2016 $34.2M
Gross Profit Q2 2016 · Jun 30, 2015 $18.44M
Gross Profit Q2 2016 · Jun 30, 2015 $40.37M
Cost Of Revenue Q2 2016 · Jun 30, 2016 $54.37M
Cost Of Revenue Q2 2016 · Jun 30, 2016 $105.32M
Cost Of Revenue Q2 2016 · Jun 30, 2015 $58.9M
Cost Of Revenue Q2 2016 · Jun 30, 2015 $119.62M